NCT00601172 2018-01-17A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.GlaxoSmithKlinePhase 3 Completed710 enrolled 29 charts
NCT00431236 2017-08-22A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic ChemotherapyGlaxoSmithKlinePhase 3 Completed810 enrolled
NCT00440128 2017-08-04The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With CancerGlaxoSmithKlinePhase 1 Completed12 enrolled
NCT00169572 2010-05-10Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based ChemotherapyGlaxoSmithKlinePhase 2 Completed492 enrolled